Issue 379 | November 21, 2017

Latest News: Spotlight One
Blog: Do Year-End Losses on Risk-Based Deals Matter?

AstraZeneca On Bridging The Gap Between Accelerated Approval And HTA Requirements

PCORI’s Selby Recaps Third Annual Meeting

Article Spotlights Need for Evidence-Based HTA for Off-Patent Products

Artificial Intelligence in the Pharma Industry

What’s Stopping Employers From Acting on Their PBMs?

Video Breaks Down Results-Based Contracts

CER Announces Final Modified Framework for Assessing Value of Treatments for Ultra-Rare Diseases

Spotlight Two
Special thanks to our partners:
Conference of the Week Webinar of the Week Latest Jobs

Research Scientist - Outcomes Research/Health Preferences

Global Market Access and Pricing Director | Chicago

Health Economic Modelling Manager

Senior Literature Review Analyst

Senior Research Analyst (HEOR)

Senior Payer Research Consultant | London / New York

Network Meta-Analysis (NMA) Statistician | London / Oxford

Link of the Week Job of the Week
Upcoming Conferences Upcoming Webinars
12th Annual EPP Global and European Pricing Forum
November 29-30
Brussels, Belgium

CBI’s Due Diligence for Life Sciences M&A, Partnerships and Divestitures
November 30-December 1
Philadelphia, Pennsylvania

The Health Technology Assessment Course - Trends and Opportunities in Europe with Prof. Dr. Lieven Annemans
November 30
Brussels, Belgium

AI and Big Data: Transforming Real-World Evidence’s Impact on Decision Making
November 28

Transition to Population-based Care Management: How Technology and Integrated Clinical Solutions Can Help You Scale
November 28

Patient-Centricity: Shaping Value Generation for HTA and Market Access
November 29


Xcendaeyeforpharma eMaxHealth Evidera Curo Jefferson HealthCoreTruven Doctor Evidence Quintiles IMS Humana OM1 Parexel Evidence Partners DRG Abacus MAPS G&J Lee Recruitment